Lennon; Kieran James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lennon; Kieran James.The latest application filed is for "immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- hthalazin-1-one".

Company Profile

2.3.10

Lennon; Kieran James - Macclesfield GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immediate Release Pharmaceutical Formulation Of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- Hthalazin-1-one App 20220249474 - Bechtold; Michael Karl ; et al.	2022-08-11
Immediate Release Pharmaceutical Formulation Of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- Hthalazin-1-one App 20200323847 - Bechtold; Michael Karl ; et al.	2020-10-15
Immediate Release Pharmaceutical Formulation Of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- Hthal App 20190365751 - Bechtold; Michael Karl ; et al.	2019-12-05
Immediate Release Pharmaceutical Formulation Of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- Hthalazin-1-one App 20180133216 - Bechtold; Michael Karl ; et al.	2018-05-17
Immediate Release Pharmaceutical Formulation Of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- Hthalazin-1-one App 20170173010 - Bechtold; Michael Karl ; et al.	2017-06-22
Immediate Release Pharmaceutical Formulation Of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- Hthalazin-1-one App 20160008473 - Bechtold; Michael Karl ; et al.	2016-01-14
Immediate Release Pharmaceutical Formulation Of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-p- Hthalazin-1-one App 20140066447 - BECHTOLD; Michael Karl ; et al.	2014-03-06
Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-p- hthalazin-1-one Grant 8,475,842 - Bechtold , et al. July 2, 2	2013-07-02
Composition 064 App 20120177705 - Blyth; John David ; et al.	2012-07-12
Composition 064 Grant 8,168,221 - Blyth , et al. May 1, 2	2012-05-01
Pharmaceutical Formulation 514 App 20100098763 - Bechtold; Michael Karl ; et al.	2010-04-22
Composition 064 App 20090099203 - Blyth; John David ; et al.	2009-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.